Mirati Therapeutics Inc (MRTX)

10.50
0.30 2.78
NASDAQ : Health Care
Prev Close 10.80
Open 11.60
Day Low/High 10.45 / 12.00
52 Wk Low/High 4.93 / 52.00
Volume 6.60M
Avg Volume 963.60K
Exchange NASDAQ
Shares Outstanding 24.97M
Market Cap 279.66M
EPS -4.20
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Mirati Therapeutics Presents Positive Preliminary Data From On-Going Clinical Trials Of Sitravatinib In Non-Small Cell Lung Cancer

Mirati Therapeutics Presents Positive Preliminary Data From On-Going Clinical Trials Of Sitravatinib In Non-Small Cell Lung Cancer

- Combination of sitravatinib and nivolumab in NSCLC patients with documented progression following checkpoint therapy demonstrated 3 confirmed Partial Responses in first 11 evaluable patients

5 Stocks Insiders Love Right Now

5 Stocks Insiders Love Right Now

Insiders at these companies -- including Opko Health and Mirati Therapeutics -- have been scooping up shares of their own stock lately.

Corporate Insiders at These 5 Companies Are Buying Large Sums of Stock

Corporate Insiders at These 5 Companies Are Buying Large Sums of Stock

Here are the names to know.

5 Stocks Under $10 That Could Make You a Lot of Money

5 Stocks Under $10 That Could Make You a Lot of Money

These stocks trading for less than $10 a share are within range of triggering big breakout trades. Here's how to trade them from here.

7 Stocks Under $10 Making Big Up Moves

7 Stocks Under $10 Making Big Up Moves

Here's a technical look at how to trade several under-$10 stocks that were making big moves to the upside recently.

First Week of MRTX August 19th Options Trading

First Week of MRTX August 19th Options Trading

Investors in Mirati Therapeutics Inc saw new options become available this week, for the August 19th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the MRTX options chain for the new August 19th contracts and identified one put and one call contract of particular interest.

These 5 Stocks Are Poised for Breakouts

These 5 Stocks Are Poised for Breakouts

These stocks are setting up to trigger big breakout trades. Here's how to trade them from here.

Relative Strength Alert For Mirati Therapeutics

Relative Strength Alert For Mirati Therapeutics

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

5 Stocks Insiders Love Right Now

5 Stocks Insiders Love Right Now

Insiders at these companies have been scooping up shares of their own stock lately.

Mirati Therapeutics Becomes Oversold (MRTX)

Mirati Therapeutics Becomes Oversold (MRTX)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Commit To Buy Mirati Therapeutics At $17.50, Earn 20.7% Annualized Using Options

Commit To Buy Mirati Therapeutics At $17.50, Earn 20.7% Annualized Using Options

Investors eyeing a purchase of Mirati Therapeutics Inc shares, but cautious about paying the going market price of $21.20/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the December put at the $17.50 strike, which has a bid at the time of this writing of $2.30.

Mirati Therapeutics Stock Sees Short Interest Decrease By 14%

Mirati Therapeutics Stock Sees Short Interest Decrease By 14%

The most recent short interest data has been released by the NASDAQ for the 03/31/2016 settlement date, which shows a 254,842 share decrease in total short interest for Mirati Therapeutics Inc , to 1,571,517, a decrease of 13.95% since 03/15/2016. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

5 Stocks Insiders Love Right Now

5 Stocks Insiders Love Right Now

Insiders at these companies have been scooping up shares of their own stock lately.

Mirati Therapeutics is Now Oversold (MRTX)

Mirati Therapeutics is Now Oversold (MRTX)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Commit To Buy Mirati Therapeutics At $17.50, Earn 13.4% Annualized Using Options

Commit To Buy Mirati Therapeutics At $17.50, Earn 13.4% Annualized Using Options

Investors considering a purchase of Mirati Therapeutics Inc stock, but cautious about paying the going market price of $23.88/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the September put at the $17.50 strike, which has a bid at the time of this writing of $1.50.

Oversold Conditions For Mirati Therapeutics

Oversold Conditions For Mirati Therapeutics

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Mirati Therapeutics Enters Oversold Territory (MRTX)

Mirati Therapeutics Enters Oversold Territory (MRTX)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Interesting MRTX Put And Call Options For November 20th

Interesting MRTX Put And Call Options For November 20th

Investors in Mirati Therapeutics Inc saw new options begin trading this week, for the November 20th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the MRTX options chain for the new November 20th contracts and identified one put and one call contract of particular interest.

Short Interest Drops 40% For MRTX

Short Interest Drops 40% For MRTX

The most recent short interest data has been released by the NASDAQ for the 08/14/2015 settlement date, which shows a 361,722 share decrease in total short interest for Mirati Therapeutics Inc , to 545,248, a decrease of 39.88% since 07/31/2015. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

Mirati Therapeutics Becomes Oversold (MRTX)

Mirati Therapeutics Becomes Oversold (MRTX)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Commit To Buy Mirati Therapeutics At $20, Earn 15.9% Annualized Using Options

Commit To Buy Mirati Therapeutics At $20, Earn 15.9% Annualized Using Options

Investors considering a purchase of Mirati Therapeutics Inc shares, but cautious about paying the going market price of $22.96/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the March 2016 put at the $20 strike, which has a bid at the time of this writing of $1.85.

Mirati Therapeutics Becomes Oversold (MRTX)

Mirati Therapeutics Becomes Oversold (MRTX)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Commit To Purchase Mirati Therapeutics At $25, Earn 22.6% Annualized Using Options

Commit To Purchase Mirati Therapeutics At $25, Earn 22.6% Annualized Using Options

Investors considering a purchase of Mirati Therapeutics Inc stock, but cautious about paying the going market price of $27.38/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the December put at the $25 strike, which has a bid at the time of this writing of $3.30.